4//SEC Filing
DuRoss Amy 4
Accession 0001628280-25-014192
CIK 0000834365other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 7:09 PM ET
Size
7.0 KB
Accession
0001628280-25-014192
Insider Transaction Report
Form 4
DuRoss Amy
Director
Transactions
- Sale
Common Stock
2025-03-14$24.96/sh−5,632$140,575→ 23,811 total - Award
Common Stock
2025-03-18+6,876→ 30,687 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-13-2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.18 to $25.91, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the measurement date of 01-02-2025.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001854968
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 7:09 PM ET
- Size
- 7.0 KB